The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced. Dubbed IsoPSA, the in vitro diagnostic kit is ...

The Python extension now supports multi-project workspaces, where each Python project within a workspace gets its own test tree and Python environment. This document explains how multi-project testing ...

NEW YORK – Quanterix said Tuesday that it has submitted a 510(k) premarket notification to the US Food and Drug Administration for its Lucent AD Complete multi-analyte algorithmic blood test for ...

One of the most pressing challenges to the continued deployment of nuclear energy systems is in the ultimate management and disposition of discharged fuel assemblies. While reprocessing and recovery ...

Non-animal framework based on new approach methodologies (NAMs) for chemical hazard identification and risk assessment. The framework comprises three modules: (1) high-throughput screening to address ...

TL;DR: Trump’s surprise hemp ban doesn’t just wipe out a massive part of the hemp-derived market; it may also create the legal framework for a broader federal crackdown on cannabis. With the Heritage ...

The FDA has granted Cleveland Diagnostics’ IsoPSA test premarket approval (PMA) to help detect prostate cancer in men aged 50 years or older with elevated PSA levels. IsoPSA is a blood assay that ...

CLEVELAND--(BUSINESS WIRE)--Cleveland Diagnostics, Inc., a pioneering, commercial-stage precision oncology company, announced today that the U.S. Food and Drug Administration (FDA) has approved the ...

IsoPSA Test Evaluates Prostate Cancer-Specific Structural Variants of the PSA Protein to Aid in the Diagnosis of High-Grade Prostate Cancer CLEVELAND--(BUSINESS WIRE)--Cleveland Diagnostics, Inc., a ...

Abstract: Monolithic 3-D (M3D) integration for integrated circuits (ICs) offers the promise of higher performance and lower power consumption over stacked-3D ICs. However, M3D suffers from large power ...